MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

A New Year, A New Spin Off

alon harel / Alamy Stock Photo IMG_2022-1-4-104906.jpg
RTI Surgical is the latest firm to spin off one of its units into a separate independent company.

RTI Surgical, a private label OEM company, is spinning off its Metal business. The new spinoff will be named Resolve Surgical Technologies.  

Alachua, Fla.-based RTI Surgical said ownership of both companies will be retained by Montagu, a private equity firm.

Resolve Surgical Technologies will act as a full-service partner covering design, development, manufacturing and regulatory support of metal and polymer implants and instruments used in orthopedics, spine, and cardiothoracic applications. RTI will continue to offer a comprehensive portfolio of tissue-based surgical implants across multiple market segments and commercial channels.

 "Our team is passionate about partnering with our customers to develop and deliver solutions that restore quality of life for patients while maximizing the gift of tissue donation,” said Olivier Visa, CEO of RTI Surgical. “With RTI Surgical's singular focus on allograft and xenograft tissue-based implants, our team will provide expanded private label solutions for customers. Our expertise includes design, development, and processing in addition to all aspects of product life cycle management, regulatory compliance and Design History File ownership.”

The Metals Business was founded in 1992 and was named Pioneer Surgical Technologies and was acquired by RTI Surgical in 2013.

The spinoff follows a trend started in 2021 of larger companies spinning off units into independent companies.

GE sparked the trend, separating its healthcare unit; its renewable energy, power, and digital businesses; and its aviation unit.

On the heels of the separation, Johnson & Johnson said it was splitting off its consumer products business from the medical device and pharma units.

 

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish